Clinical Manifestations, Diagnosis, Management and Prevention of Cervical Cancer
Authors
Sastraningsih Setiawati , Yunita HapsariDOI:
10.29303/jbt.v23i4.5594Published:
2023-09-17Issue:
Vol. 23 No. 4 (2023): October - DecemberKeywords:
Cancer, cervical, pap smear, HPV.Articles
Downloads
How to Cite
Downloads
Metrics
Abstract
The second most prevalent cancer in women and one that may be mainly prevented or treated if discovered at an early stage, cervical cancer is a serious health concern worldwide, particularly in Indonesia. This literature review aims to provide related information about clinical manifestations, diagnosis, management and prevention of cervical cancer. We searched online databases and used review articles, research, guidelines from professional organizations, such as POGI from Indonesia and FIGO from London. The disease's clinical manifestations often appear in advanced stages and can include abnormal vaginal bleeding, pelvic pain, and pain during intercourse. Diagnosis typically involves a multi-step process beginning with physical examination, Pap smear tests, HPV testing, and possibly leading to colposcopy and biopsy procedures for confirmatory analysis. Management strategies for cervical cancer range from conservative watch-and-wait approaches in early-stage disease to more aggressive interventions such as surgery, radiation, and chemotherapy in more advanced cases. Prevention strategies have centered on HPV vaccination and regular screening tests, both of which remain underutilized in regions like Indonesia. Despite the availability of effective preventative and therapeutic measures, the high incidence and mortality rates emphasize the critical need for enhanced public health efforts to increase screening and vaccination rates, improve access to treatment, and promote education on cervical cancer. Cervical cancer usually does not appear until the cancer has reached an advanced stage trough increased awareness, education, and access to screening and treatment services, the burden of cervical cancer can be reduced.
References
Amanda, M. R., Sastradinata, I., Agustiansyah, P., Bahar, E., Nindrea, R. D., Obstetri, B., Kedokteran, F., & Sriwijaya, U. (2017). Kanker serviks pada wanita. Journal Endurance, 2(February), 53–61. https://doi.org/http://dx.doi.org/10.22216/jen.v2i1.1538
Arbyn, M., Weiderpass, E., Bruni, L., de Sanjosé,
S., Saraiya, M., Ferlay, J., & Bray, F. (2020). Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet Global Health, 8(2), e191-e203. https://doi.org/10.1016/S2214109X(19)30482-6
Bhatla, N., Aoki, D., Sharma, D. N., &
Sankaranarayanan, R. (2018). Cancer of the cervix uteri. International Journal of Gynecology & Obstetrics, 143, 22-36. https://doi.org/10.1002/ijgo.12611
Cancer Research UK. (2019). Cervical cancer statistics. https://www.cancerresearchuk.org/
Castle, P. E., & Maza, M. (2016). Prophylactic
HPV vaccination: Past, present, and future. Epidemiology and infection, 144(3), 449-468. https://doi.org/10.1017/S0950268815002198
Centers for Disease Control and Prevention, C. (2021). What Do My Cervical Cancer Screening Test Results Mean? | CDC. Centers for Disease Control and Prevention (CDC). https://www.cdc.gov/cancer/cervical/basic_info/test-results.htm
Cheung, L. C., Egemen, D., Chen, X., Katki, H. A., Demarco, M., Wiser, A. L., Perkins, R. B., Guido, R. S., Wentzensen, N., & Schiffman, M. (2020). 2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation. In Journal of Lower Genital Tract Disease (Vol. 24, Issue 2). https://doi.org/10.1097/LGT.0000000000000528
Desen, W. (2013). Buku ajar onkologi klinis Ed 2. Jakarta : Balai penerbit FKUI
Dewi, I. G. A. A. N., Sawitri, A. A. S., & Adiputra, N. (2013). Laporan hasil penelitian Paparan asap rokok dan higiene diri merupakan faktor risiko lesi prakanker leher rahim di Kota Denpasar tahun 2012 Cigarette smoke exposure and personal hygiene as determinants for cervical pre- cancer lession in Denpasar , 2012 P. Public Health and Preventive Medicine Archive, 1(1), 84–91. https://doi.org/https://doi.org/10.24252/as.v6i2.19
Fitrisia, C. A., Khambri, D., Utama, B. I., & Muhammad, S. (2020). Analisis Faktor-faktor yang Berhubungan dengan Kejadian Lesi Pra Kanker Serviks pada Wanita Pasangan Usia Subur di Wilayah Kerja Puskesmas Muara Bungo 1. Jurnal Kesehatan Andalas, 8(4), 33–43. https://doi.org/10.25077/jka.v8i4.1147
Fontham, E. T., Wolf, A. M., Church, T. R., Etzioni, R., Flowers, C. R., Herzig, A., ... & Wender, R. (2020). Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA: a cancer journal for clinicians, 70(5), 321-346. https://doi.org/10.3322/caac.21628
Ginindza, T. G., Dlamini, X., Almonte, M., Herrero, R., Jolly, P. E., Tsoka-Gwegweni, J. M., Weiderpass, E., Broutet, N., & Sartorius, B. (2017). Prevalence of and associated risk factors for high risk human papillomavirus among sexually active women, Swaziland. PLoS ONE, 12(1), 1–18. https://doi.org/10.1371/journal.pone.0170189
Kemenkes RI. (2019). Pedoman Nasional Pelayanan Kedokteran Tatalaksana Kanker Serviks. Jakarta
Khairi, A., Tawajjuh, N., Winarti, S., & Made Mulyani, N. (2020). Gambaran Epidemiologi Kejadian Kanker Servik di Rumah Sakit Umum Daerah Provinsi Nusa Tenggara Barat The Epidemiological Of Cervical Cancer In General Hospital of West Nusa Tenggara Province. Caring, 4(1), 7–12. https://doi.org/https://doi.org/10.36474/caring.v4i1.159 0CITATIONS0 total citations on Dimensions.
Lipinwati. (2014). Diagnosis molekuler human papilloma virus (HPV) penyebab kanker serviks. Jambi Medical Journal, 2(1), 78–86. https://doi.org/https://doi.org/10.22437/jmj.v2i1.2701
Lubis, R. C., Siregar, F. A., & Sanusi, sri R. (2017). Pengaruh Usia Pertama Kali Melakukan Hubungan. Muara Sains, Teknologi, Kedeokteran Dan Ilmu Kesehatan, 1(2), 145–152. https://doi.org/https://doi.org/10.24912/jmstkik.v1i2.1034
Ministry of Health, Republic of Indonesia. (2015). Data and Information: Indonesia Health Profile Year 2015. http://www.depkes.go.id
Munro, A., Codde, J., Spilsbury, K., Stewart, C. J., Steel, N., Leung, Y., ... & O'leary, P. (2017). Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins. Acta obstetricia et gynecologica Scandinavica, 96(5), 548-555. https://doi.org/10.1111/aogs.13098
Pan American Health Organization. (2016). Integrating HPV Testing in Cervical Cancer Screening Programs.
Perhimpunan Obstetri dan Ginekologi Indonesia (POGI). (2015). Pedoman Pelayanan Medis Kanker Serviks. Jakarta: POGI.
Pimple SA, Mishra GA. Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges. Minerva Ginecol. 2019 Oct;71(5):365-371. https://doi.org/10.23736/S00264784.19.04468-X. PMID: 31698891.
Plummer, M., Peto, J., & Franceschi, S. (2012). Time since first sexual intercourse and the risk of cervical cancer. International journal of cancer, 130(11), 2638-2644. https://doi.org/10.1002/ijc.26250
Putra, S. P., & Putra, A. E. (2021). Upaya Pencegahan Kanker Serviks melalui Vaksinasi dan Skrining Human Papillomavirus. Majalah Kedokteran Andalas, 44(2), 126–134. https://doi.org/https://doi.org/10.25077/mka.v44.i2.p125-133.2021
Schiffman, M., Doorbar, J., Wentzensen, N., De Sanjose, S., Fakhry, C., Monk, B. J., ... & Stanley, M. A. (2016). Carcinogenic human papillomavirus infection. Nature Reviews Disease Primers, 2(1), 1-20. https://doi.org/10.1038/nrdp.2016.86
Setiawati, D. (2014). Human Papilloma Virus Dan Kanker Serviks. Al-Sihah : Public Health Science Journal, VI(2), 450–451. https://doi.org/https://doi.org/10.24252/as.v6i2.1969
Shabbir, M., Barod, R., Hegarty, P. K., & Minhas, S. (2013). Primary prevention and vaccination for penile cancer. Therapeutic Advances in Urology, 5(3), 161–169. https://doi.org/10.1177/1756287212465456
Small Jr, W., Bacon, M. A., Bajaj, A., Chuang, L. T., Fisher, B. J., Harkenrider, M. M., Jhingran, A., Kitchener, H. C., Mileshkin, L. R., Viswanathan, A. N., & Gaffney, D. K. (2017). Cervical cancer: A global health crisis. Cancer, 123(13), 2404-2412. https://doi.org/10.1002/cncr.30667
Stanley, M. A. (2010). Pathology and epidemiology of HPV infection in females. Gynecologic oncology, 117(2), S5-S10. https://doi.org/10.1016/j.ygyno.2010.01.024
Sulistiya, D. P., Pramono, D., & Nurdiati, D. (2017). Faktor-faktor yang berhubungan dengan kejadian kanker serviks di RSUP Dr. Sardjito Yogyakarta. Berita Kedokteran Masyarakat, 33(3), 125. https://doi.org/10.22146/bkm.17160
Susianti, & Aulia, W. (2017). Pengobatan Karsinoma Serviks. Majority, 6(2), 91–97. https://doi.org/https://doi.org/10.24252/as.v6i2.1969
Swardewa, T. G. A. (2017). Pendidikan Kedokteran Berkelanjutan ke-8 Obstetrik & Ginekologi. Gastronomía Ecuatoriana y Turismo Local., 1(69), 5–24.
Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., ... & Munoz, N. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of pathology, 189(1), 12-19. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
Widyaswari, M. S., Lumintang, H., & Soemarno, T. (2019). Imunohistokimia Pada Kondilomata Akuminata. Medical and Health Science Journal, 3(1), 47–54. https://doi.org/10.33086/mhsj.v3i1.926
World Health Organization (WHO). (2020). Comprehensive cervical cancer control: a guide to essential practice. https://www.who.int/
World Health Organization, W. (2023). Cervical cancer. https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
Wright Jr, T. C., Stoler, M. H., Behrens, C. M., Sharma, A., Zhang, G., & Wright, T. L. (2015). Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test. Gynecologic oncology, 136(2), 189-197. https://doi.org/10.1016/j.ygyno.2014.11.076
Yamaguchi, M., Sekine, M., Hanley, S. J. B., Kudo, R., Hara, M., Adachi, S., Ueda, Y., Miyagi, E., & Enomoto, T. (2021). Risk factors for HPV infection and high-grade cervical disease in sexually active Japanese women. Scientific Reports, 11(1), 1–9. https://doi.org/10.1038/s41598-021-82354-6
Yunita Hapsari, Dedianto Hidajat, Rika Hastuti Setyorini, & Farida Hartati. (2019). Prevalensi dan Faktor Risiko Highrisk HPV Pada Inspeksi Visual Asam Asetat Positif Di Mataram NTB. Unram Medical Journal, 8(2), 12. https://doi.org/10.29303/jku.v8i2.337
Zhang, S., Xu, H., Zhang, L., & Qiao, Y. (2020). Cervical cancer: Epidemiology, risk factors and screening. Chinese Journal of Cancer Research, 32(6), 720–728. https://doi.org/10.21147/j.issn.1000-9604.2020.06.05
License
Copyright (c) 2023 Sastraningsih Setiawati, Yunita Hapsari
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.